436 related articles for article (PubMed ID: 23229750)
1. My journey into the world of sphingolipids and sphingolipidoses.
Sandhoff K
Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750
[TBL] [Abstract][Full Text] [Related]
2. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
Sandhoff K
Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and cellular bases of sphingolipidoses.
Sandhoff K
Biochem Soc Trans; 2013 Dec; 41(6):1562-8. PubMed ID: 24256255
[TBL] [Abstract][Full Text] [Related]
4. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.
Kolter T; Sandhoff K
Annu Rev Cell Dev Biol; 2005; 21():81-103. PubMed ID: 16212488
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
Sandhoff K; Kolter T; Van Echten-Deckert G
Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
[TBL] [Abstract][Full Text] [Related]
6. A view on sphingolipids and disease.
Kolter T
Chem Phys Lipids; 2011 Sep; 164(6):590-606. PubMed ID: 21570958
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the biochemistry of sphingolipidoses.
Kolter T; Sandhoff K
Brain Pathol; 1998 Jan; 8(1):79-100. PubMed ID: 9458169
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
[TBL] [Abstract][Full Text] [Related]
9. Characterization of
Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
[TBL] [Abstract][Full Text] [Related]
10. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
11. Niemann-Pick type C disease: The atypical sphingolipidosis.
Newton J; Milstien S; Spiegel S
Adv Biol Regul; 2018 Dec; 70():82-88. PubMed ID: 30205942
[TBL] [Abstract][Full Text] [Related]
12. The biochemistry of sphingolipid storage diseases.
Sandhoff K
Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
[No Abstract] [Full Text] [Related]
13. [Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].
Hirabayashi Y; Li YT; Li SC
Seikagaku; 1983; 55(1):1-13. PubMed ID: 6405000
[No Abstract] [Full Text] [Related]
14. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
15. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.
Platt FM
Biochem Soc Trans; 2023 Oct; 51(5):1777-1787. PubMed ID: 37844193
[TBL] [Abstract][Full Text] [Related]
16. Sphingolipids and lysosomal pathologies.
Schulze H; Sandhoff K
Biochim Biophys Acta; 2014 May; 1841(5):799-810. PubMed ID: 24184515
[TBL] [Abstract][Full Text] [Related]
17. Pathology and current treatment of neurodegenerative sphingolipidoses.
Eckhardt M
Neuromolecular Med; 2010 Dec; 12(4):362-82. PubMed ID: 20730629
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal Glycosphingolipid Storage Diseases.
Breiden B; Sandhoff K
Annu Rev Biochem; 2019 Jun; 88():461-485. PubMed ID: 31220974
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
20. Emerging mechanisms of drug-induced phospholipidosis.
Breiden B; Sandhoff K
Biol Chem; 2019 Dec; 401(1):31-46. PubMed ID: 31408430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
